Dr. Lian Ni Lee

Dr. Lian Ni Lee is a seasoned immunologist and co-founder of Infinitopes Precision Immunomics, bringing deep expertise in T-cell biology that she developed across leading academic and industry environments. She earned her PhD in Immunology from University College London before gaining industry experience at GSK and Pfizer and most recently conducting cutting-edge cancer vaccine research at the University of Oxford.

At Oxford, supported by funding from Cancer Research UK and the Emerson Collective, Lian led pioneering studies into cancer vaccine development that directly underpinned Infinitopes' founding science. She co-founded the company in 2021 alongside Dr. Jonathan Kwok and Dr. Senthil Chinnakannan, serving as VP Preclinical and building Infinitopes' in-house laboratory team from the ground up.

As one of the three academic co-founders who transformed Oxford University IP into a clinical-stage company, Lian has been instrumental in advancing Infinitopes' Precision Immunomics platform toward its first-in-human Phase I/IIa trial of ITOP1, a cancer vaccine targeting oesophageal cancer. Her work represents the bridge between world-leading academic immunology and real-world cancer therapeutics.